Medicine and Dentistry
Liver Transplantation
100%
Fibrosis
97%
Hepatitis C Virus
76%
Inflammatory Bowel Disease
64%
Hepatitis C
38%
Liver Graft
36%
Liver Biopsy
36%
Acute Graft Rejection
35%
Disease Course
34%
Treatment Response
32%
Liver Disease
32%
Sclerosing Cholangitis
32%
Cohort Analysis
32%
Chronic Hepatitis C
32%
Primary Sclerosing Cholangitis
32%
Antivirus Agent
32%
FibroScan
32%
Tacrolimus
32%
Recurrent Disease
32%
microRNA
32%
Autoimmunity
32%
Liver Cirrhosis
26%
Side Effect
24%
Antiviral Therapy
22%
Proteinase Inhibitor
16%
Ribavirin
16%
Peginterferon
16%
Diseases
16%
Colectomy
8%
Telaprevir
8%
Boceprevir
8%
Recurrence Risk
8%
Drug Dose Regimen
8%
Anemia
8%
Graft Survival
7%
Inflammatory Bowel Disease Therapy
6%
Biopsy Technique
5%
Pharmacology, Toxicology and Pharmaceutical Science
Fibrosis
97%
Hepatitis C Virus
76%
Hepatitis B Virus
60%
Peginterferon
48%
Hepatitis C
38%
Chronic Hepatitis B
32%
Acute Graft Rejection
32%
Combination Therapy
32%
HIV
32%
Tenofovir
32%
Viremia
32%
Recurrent Disease
32%
Mixed Infection
32%
Antivirus Agent
32%
microRNA
32%
Chronic Hepatitis C
32%
Liver Cirrhosis
26%
Side Effect
24%
Virus DNA
22%
Antiviral Therapy
22%
Tenofovir Disoproxil
18%
Proteinase Inhibitor
16%
Diseases
16%
Lamivudine
16%
Ribavirin
16%
Hepatitis B(e) Antibody
14%
Hepatitis B(e) Antigen
10%
Hepatitis B Antigen
10%
Telaprevir
8%
Boceprevir
8%
Recurrence Risk
8%
Anemia
8%
Emtricitabine
8%
Fumaric Acid
5%
Entecavir
5%
Immunology and Microbiology
Liver Transplantation
96%
Inflammatory Bowel Disease
64%
Acute Graft Rejection
35%
Hepatitis C Virus
32%
Primary Sclerosing Cholangitis
32%
Tacrolimus
32%
Blood Plasma
32%
Pegylated Interferon
32%
Hepatitis B
32%
Wiskott-Aldrich Syndrome
32%
Autoimmunity
32%
HBV DNA
28%
Hepatitis B(e) Antibody
14%
Seroconversion
14%
HBsAg
10%
Hepatitis B(e) Antigen
10%
Hepatitis B Antigen
10%